Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Genprex, Inc. - Common Stock
(NQ:
GNPX
)
0.2750
+0.0205 (+8.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Genprex, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 04, 2022
Gainers Hoth Therapeutics (NASDAQ:
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
January 04, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...
Via
Benzinga
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Oncology R&D Pipeline to Include Small Cell Lung Cancer
January 04, 2022
Via
Investor Brand Network
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer
January 04, 2022
From
Genprex, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 04, 2022
Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
January 03, 2022
Gainers Indaptus Therapeutics (NASDAQ:INDP
Via
Benzinga
61 Biggest Movers From Yesterday
January 04, 2022
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 03, 2022
Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million...
Via
Benzinga
CCL Stock: Why Carnival Is Cruising Higher Despite the CDC’s Covid Call
January 03, 2022
Carnival (CCL) stock is heading higher on Monday despite recent concerns about the Covid-19 Omicron variant and CDC warnings.
Via
InvestorPlace
TSM Stock: What Investors Are Saying About the Taiwan Semiconductor Breakout Today
January 03, 2022
Taiwan Semiconductor (TSM) stock is getting a nice boost today alongside heavy trading even without any news surrounding the company today.
Via
InvestorPlace
Dow Flat as Tesla Lifts Tech, Autos
January 03, 2022
The Dow Jones Industrial Average is flat midday, as it cools off from this morning's burst higher. Both the S&P 500 Index and Nasdaq Composite are more comfortably in the black.
Via
Talk Markets
GNPX Stock: 5 Things to Know as Genprex Rockets Higher
January 03, 2022
Shares of GNPX stock are soaring higher after the FDA granted fast track designation (FTD) for the company's lead drug candidate, REQORSA.
Via
InvestorPlace
8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE
January 03, 2022
We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading.
Via
InvestorPlace
Why Genprex Shares Are Soaring Today
January 03, 2022
Genprex Inc (NASDAQ: GNPX) is trading higher Monday after the company announced it received U.S. Food and Drug Administration Fast Track Designation (FTD) for REQORSA...
Via
Benzinga
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Granted Fast Track Designation for Proprietary Immunogene Therapy from FDA
January 03, 2022
Via
Investor Brand Network
Exposures
Product Safety
Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting
January 03, 2022
The FDA has granted Fast Track Designation for Genprex Inc's (NASDAQ: GNPX) lead drug candidate, Reqorsa Immunogene combination therapy. The designation...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 03, 2022
Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The company's market cap stands at $43.5 million....
Via
Benzinga
Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
January 03, 2022
From
Genprex, Inc.
Via
Business Wire
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO to Present in CEO Roadshow Webinar
November 16, 2021
Via
Investor Brand Network
Genprex to Present in November CEO Roadshow Webinar
November 16, 2021
From
Genprex, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 27, 2021
Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 20, 2021
Gainers Tenet Healthcare (NYSE:THC) stock r...
Via
Benzinga
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Strengthens Management Team with Strategic Appointments
September 28, 2021
Via
Investor Brand Network
Genprex Strengthens Management Team with Appointments of Industry Leaders Mark S. Berger, M.D. as Chief Medical Officer and Hemant Kumar, Ph.D. as Chief Manufacturing and Technology Officer
September 28, 2021
From
Genprex, Inc.
Via
Business Wire
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation in Two Upcoming Investor Conferences
September 20, 2021
Via
Investor Brand Network
Genprex to Participate in September Investor Conferences
September 20, 2021
From
Genprex, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
August 26, 2021
Gainers MorphoSys (NASDAQ:MOR) stock move...
Via
Benzinga
Genprex to Participate in a Monthly CEO Roadshow Webinar Series
July 20, 2021
From
Genprex, Inc.
Via
Business Wire
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.